Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REGENXBIO Inc. (RGNX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Dec-31-22 | Dec-05-22 | Sep-05-22 | Jun-30-22 | Jun-05-22 |
| | 10-Q | 8-K | 10-Q | 10-K | 8-K | 8-K | 10-Q | 8-K |
| Revenues | | | | 100.0% | | | 100.0% | |
| Cost of goods sold | | | | 48.4% | | | 13.5% | |
| Gross profit | | | | 51.6% | | | 86.5% | |
| Selling, general and administrative | | | | 229.1% | | | 51.0% | |
| General and administrative | | | | 189.7% | | | | |
| EBITDA | | | | -246.9% | | | 19.4% | |
| Depreciation | | | | 16.1% | | | 1.6% | |
| EBIT | | | | -262.9% | | | 17.8% | |
| Pre-tax income | | | | -248.8% | | | 21.3% | |
| Income taxes | | | | -0.1% | | | 2.7% | |
| Net income | | | | -248.7% | | | 18.6% | |
|